Detalles de la búsqueda
1.
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
J Immunother Cancer
; 12(5)2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754916
2.
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.
J Immunother Cancer
; 10(9)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167468
3.
Effects of Chemotherapy Agents on Circulating Leukocyte Populations: Potential Implications for the Success of CAR-T Cell Therapies.
Cancers (Basel)
; 13(9)2021 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34066414
Resultados
1 -
3
de 3
1
Próxima >
>>